PSG clean claim rate
DMEPOS revenue increase
Overall denial rate
Average payment cycle
Sleep medicine billing revolves around a specific set of high-value procedural codes that demand meticulous documentation and strict adherence to payer-specific coverage criteria. In-lab polysomnography (95810 for attended with CPAP, 95811 for attended with additional parameters) generates substantial revenue per study, but reimbursement depends on documenting medical necessity through validated screening tools and referring physician orders. Home sleep testing (95800 for unattended with airflow, 95801 with additional channels) has grown rapidly, and the lower reimbursement per test requires volume efficiency and clean claim submission to maintain profitability.
Our billing team manages the complete sleep medicine revenue cycle, from initial consultation E/M coding through diagnostic studies, split-night protocols, CPAP titration, and the ongoing DMEPOS supply chain billing that represents a significant recurring revenue stream. We handle the MSLT (95805) and MWT coding for narcolepsy workups, the prior authorization requirements that most payers impose on in-lab studies, and the compliance documentation needed for Medicare’s face-to-face clinical evaluation requirement before sleep testing. For labs billing both professional and technical components, we ensure proper modifier 26/TC application and facility fee capture.
Every Sleep Medicine billing team deals with payer delays, coding nuance, and collection leakage. We tighten those weak points before they turn into write-offs.
PSG studies (95810-95811) require documented clinical indications, validated screening scores, and complete channel recording data. Incomplete documentation is the primary cause of sleep study denials across all payers.
HST codes (95800-95801) reimburse at 30-40% of in-lab PSG rates. Maintaining profitability requires high first-pass acceptance rates, efficient interpretation workflows, and minimal rework on claims.
CPAP equipment (E0601) and ongoing supplies (masks, tubing, filters) generate recurring revenue but require compliance tracking, usage data verification, and timely reorder billing to maintain the supply revenue stream.
Split-night studies (diagnostic followed by CPAP titration in one session) must meet specific AHI thresholds during the diagnostic portion. If threshold criteria are not documented, payers deny the titration portion of the study.
Support spans the full revenue cycle, from front-end verification to denial recovery and reporting.
In-lab polysomnography billing and coding
Home sleep test claim management
CPAP and DMEPOS supply billing
Prior authorization for sleep studies
Split-night and MSLT/MWT procedure coding
Medicare compliance and LCD adherence
We support independent practices, multisite groups, and growing provider organizations with flexible workflows.
Independent physician groups
Multi-location practices
Private equity backed platforms
Hospital-owned outpatient groups
Sleep medicine billing revolves around a specific set of high-value procedural codes that demand meticulous documentation and strict adherence to payer-specific coverage criteria. In-lab polysomnography (95810 for attended with CPAP, 95811 for attended with additional parameters) generates substantial revenue per study, but reimbursement depends on documenting medical necessity through validated screening tools and referring physician orders. Home sleep testing (95800 for unattended with airflow, 95801 with additional channels) has grown rapidly, and the lower reimbursement per test requires volume efficiency and clean claim submission to maintain profitability.
Our billing team manages the complete sleep medicine revenue cycle, from initial consultation E/M coding through diagnostic studies, split-night protocols, CPAP titration, and the ongoing DMEPOS supply chain billing that represents a significant recurring revenue stream. We handle the MSLT (95805) and MWT coding for narcolepsy workups, the prior authorization requirements that most payers impose on in-lab studies, and the compliance documentation needed for Medicare’s face-to-face clinical evaluation requirement before sleep testing. For labs billing both professional and technical components, we ensure proper modifier 26/TC application and facility fee capture.
Answers to the questions practice owners and managers ask most often before switching billing partners.
We verify that clinical documentation includes validated screening tool scores (Epworth, STOP-BANG), documented comorbidities that support medical necessity, and a qualifying referring physician order before submitting PSG claims. This pre-submission review catches the documentation gaps that cause 70% of sleep study denials.
Yes. For labs that bill both components, we apply modifier 26 for the interpreting physician's professional fee and modifier TC for the facility's technical component. For global billing arrangements, we submit without modifiers and ensure the combined reimbursement matches contracted rates.
We track each patient's supply replacement schedule (masks every 3 months, tubing every 3 months, filters monthly), verify CPAP compliance data meets the minimum 4-hour usage threshold, and process reorder claims on the earliest eligible date to maintain consistent supply revenue.
We code HST studies (95800-95801) with proper documentation of the type III or type IV device used, ensure the interpreting physician's credentials meet payer requirements, and submit with the clinical indications that demonstrate why a home test was appropriate versus an in-lab study.
We ensure compliance with Medicare's LCD for sleep testing, including the required face-to-face clinical evaluation before the study, documentation of symptoms meeting coverage criteria, and proper ordering physician credentials. We also manage the Medicare CPAP compliance trial period documentation.
Our sleep lab clients see denial rates drop to 4-6% (from industry averages of 12-18%), DMEPOS supply revenue increases of 25-35% through consistent reorder management, and overall revenue improvements of 15-20% within the first year.
The difference is operational discipline. We focus on clean submissions, fast follow-up, and transparency.
Get a revenue review and a clear action plan tailored to your practice, payers, and claim mix.